- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1865-5076
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
ASH 2018—Highlights in Multiple Myeloma ; volume:12 ; number:3 ; day:12 ; month:8 ; year:2019 ; pages:203-206 ; date:9.2019
Magazine of European Medical Oncology ; 12, Heft 3 (12.8.2019), 203-206, 9.2019
- Urheber
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s12254-019-0515-4
- URN
-
urn:nbn:de:101:1-2020020419241722912190
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:52 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Jeryczynski, Georg
- Krauth, Maria
- SpringerLink (Online service)
Ähnliche Objekte (12)
ASH highlights 2022—multiple myeloma
Multiple myeloma: my highlights at ASH 2020
The molecular make up of smoldering myeloma highlights the evolutionary pathways leading to multiple myeloma
Bispecific Monoclonal Antibodies in Multiple Myeloma: Data from ASH 2022: A Podcast
Multiple myeloma
ASH highlights 2019: “aggressive B-cell lymphoma”
Immunotherapies targeting GPRC5D in relapsed or refractory multiple myeloma: latest updates from 2022 ASH Annual Meeting
Imaging of Multiple Myeloma
ESMO 2018—personal highlights
Analysis of the genomic landscape of multiple myeloma highlights novel prognostic markers and disease subgroups
Multiple myeloma in Armenia during the period 2006–2018: facts and discussion
Components of metabolic syndrome in patients with multiple myeloma and smoldering multiple myeloma
ASH highlights 2022—multiple myeloma
Multiple myeloma: my highlights at ASH 2020
The molecular make up of smoldering myeloma highlights the evolutionary pathways leading to multiple myeloma
Bispecific Monoclonal Antibodies in Multiple Myeloma: Data from ASH 2022: A Podcast
Multiple myeloma
ASH highlights 2019: “aggressive B-cell lymphoma”
Immunotherapies targeting GPRC5D in relapsed or refractory multiple myeloma: latest updates from 2022 ASH Annual Meeting
Imaging of Multiple Myeloma
ESMO 2018—personal highlights
Analysis of the genomic landscape of multiple myeloma highlights novel prognostic markers and disease subgroups
Multiple myeloma in Armenia during the period 2006–2018: facts and discussion
Components of metabolic syndrome in patients with multiple myeloma and smoldering multiple myeloma
ASH highlights 2022—multiple myeloma
Multiple myeloma: my highlights at ASH 2020
The molecular make up of smoldering myeloma highlights the evolutionary pathways leading to multiple myeloma
Bispecific Monoclonal Antibodies in Multiple Myeloma: Data from ASH 2022: A Podcast
Multiple myeloma
ASH highlights 2019: “aggressive B-cell lymphoma”
Immunotherapies targeting GPRC5D in relapsed or refractory multiple myeloma: latest updates from 2022 ASH Annual Meeting
Imaging of Multiple Myeloma
ESMO 2018—personal highlights
Analysis of the genomic landscape of multiple myeloma highlights novel prognostic markers and disease subgroups
Multiple myeloma in Armenia during the period 2006–2018: facts and discussion